Z-Medica Awarded a Novation Innovative Technology Contract Covering QuikClot®

Share Article

Z-Medica, LLC, a leading developer and marketer of hemostatic devices, announces today receipt of an Innovative Technology Contract for the company’s QuikClot® products from Novation, a leading health care services company.

Z-Medica, LLC, a leading developer and marketer of hemostatic devices, announces today receipt of an Innovative Technology Contract for the company’s QuikClot® products from Novation, a leading health care services company.

Novation serves more than 100,000 members and affiliates of VHA Inc., UHC, Children’s Hospital Association and Provista. In 2013, these health care organizations purchased $49 billion of products and services through Novation contracts.

Novation’s Innovative Technology program seeks to identify and contract for innovative medical products used in the clinical care of patients that offer an incremental benefit to patient care, or patient or healthcare worker safety. The process includes review by a clinical member council or task force to determine whether the technology represents an incremental advantage for providers.

“This is the first Novation contract for Z-Medica and QuikClot,” says Z-Medica President and CEO Stephen J. Fanning. “We are excited as we feel QuikClot brings superior clinical, strategic and economic value to the health care organizations they serve. Moreover, being part of the Innovative Technology category further supports Z-Medica's mission to provide 'best in class' hemostatic products, with applications throughout the hospital setting.”

About Z-Medica®, LLC
Z-Medica, LLC is a medical device company founded in 2002 developing fast acting, easy to use, hemostatic products that stop bleeding wherever it occurs, making it possible to save lives and improve patient outcomes. Based on tests conducted by the Naval Medical Research Center and the U.S. Army Institute for Surgical Research, the Committee on Tactical Combat Casualty Care (CoTCCC) recommended QuikClot Combat Gauze® as the hemostatic agent for the Department of Defense and for use by all U.S. military forces as the first line hemostatic agent for traumatic bleeding for compressible hemorrhage. QuikClot® products are developed and manufactured in the United States. Z-Medica, LLC is a privately-held company based in Wallingford, CT. For more information, visit http://www.quikclot.com    

About Novation, Recipient of the Ethisphere Institute’s Ethics Inside Certification
Novation is the nation’s leading health care services company, focused on revolutionizing operational performance for more than 100,000 members and affiliates of VHA Inc., UHC, Children's Hospital Association and Provista LLC. Novation’s progressive approach to cost performance, data and intelligence, and integrated advisory solutions helps health care providers envision and advance new models of cost-effective, high-quality care. Headquartered in Irving, Texas, Novation is committed to the highest standards of ethical behavior and twice has been honored with the Ethisphere Institute’s coveted Ethics Inside® Certification, and has been named three years consecutively to Ethisphere’s World’s Most Ethical Companies list. To learn more about Novation, please visit novationco.com and follow @NovationNews on Twitter.

Company Contact:
Dave Schemelia / EVC Group
dave(at)evcgoup(dot)com
646-201-5431

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dave Schemelia
EVC Group
+1 (646) 201-5431
Email >